Working… Menu

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03687242
Recruitment Status : Active, not recruiting
First Posted : September 27, 2018
Last Update Posted : June 26, 2019
Information provided by (Responsible Party):
Spruce Biosciences

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 19, 2019
Estimated Study Completion Date : September 6, 2019